Skip to main content
Watch Insiders

Corporate insider profile

James B. Tananbaum Insider Trades

Latest reported as Director / 10% Owner of Latigo Biotherapeutics, Inc. (LTGO).

Purchase filings
1
Reported companies
1
Net open-market value
$2,520,000
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

LTGOLatest reported

Latigo Biotherapeutics, Inc.

Director / 10% Owner

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026Latigo Biotherapeutics, Inc. (LTGO)Director / 10% OwnerOpen Market Purchase140,000$18.00$2,520,000